A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
Condition: Adult Male HypogonadismIntervention: Drug: Testosterone Gel (FE 999303)Sponsor: Ferring PharmaceuticalsRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 28, 2014 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
Condition: Adult Male HypogonadismIntervention: Drug: Testosterone Gel (FE 999303)Sponsor: Ferring PharmaceuticalsActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2014 Category: Research Source Type: clinical trials
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
Condition: Secondary HypogonadismInterventions: Drug: Androxal 12.5 mg or 25 mg; Drug: AndroGel 1.62%; Drug: Placebo Capsules; Drug: Placebo GelSponsor: Repros Therapeutics Inc.Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2013 Category: Research Source Type: clinical trials
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
Condition: Secondary HypogonadismInterventions: Drug: Androxal 12.5 mg/25 mg; Drug: Placebo Capsules; Drug: AndroGel 1.62%; Drug: Placebo GelSponsor: Repros Therapeutics Inc.Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2013 Category: Research Source Type: clinical trials
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
Condition: Secondary HypogonadismInterventions: Drug: Androxal 12.5 mg or 25 mg; Drug: AndroGel 1.62%; Drug: Placebo Capsules; Drug: Placebo GelSponsor: Repros Therapeutics Inc.Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2013 Category: Research Source Type: clinical trials
A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel
Condition: Male HypogonadismIntervention: Drug: Testosterone GelSponsor: Ferring PharmaceuticalsCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2012 Category: Research Source Type: clinical trials
